Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 170

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Role of Striatal Serotonin2A and Serotonin2C Receptor Subtypes in the Control of In Vivo Dopamine Outflow in the Rat Striatum

Lucas, Guillaume, Spampinato, Umberto·2000·Journal of Neurochemistry

Abstract

Abstract: This study investigated, using in vivo microdialysis in the striatum of freely moving rats, the role of striatal serotonin 2A (5‐HT 2A) and 5‐HT 2C receptor subtypes in the modulation of dopamine (DA) and 3, 4‐dihydroxyphenylacetic acid (DOPAC) outflow, both in basal conditions and under activation induced by subcutaneous administration of 0.01 mg/kg haloperidol. The different 5‐HT 2 agents used were applied intrastriatally at a 1 μ M concentration through the microdialysis probe. Basal DA efflux was enhanced (27%) by the 5‐HT 2A/2B/2C agonist 1‐(4‐iodo‐2,5‐dimethoxyphenyl)‐2‐aminopropane (DOI) and reduced (‐30%) by the 5‐HT 2B/2C antagonist SB 206553. It was unaffected by infusion of the 5‐HT 2A antagonist SR 46349B. The effect of DOI was abolished by SB 206553 but not modified by SR 46349B. Haloperidol‐stimulated DA efflux (65‐70%) was reduced by both SR 46349B (‐32%) and the 5‐HT 2A/2B/2C antagonist ritanserin (‐30%) but not affected by SB 206553. Conversely, the effect of haloperidol was potentiated (22%) when DOI was coperfused with SB 206553. Also, haloperidol‐stimulated DOPAC outflow (40‐45%) was reduced (‐20%) by SR 46349B and potentiated (25%) by the combination of SB 206553 with DOI. These results indicate that striatal 5‐HT 2A receptors, probably through activation of DA synthesis, positively modulate DA outflow only under activated conditions. In contrast, striatal 5‐HT 2C receptors exert a facilitatory control on basal DA efflux, which appears to be both tonic and phasic.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1471-4159.2000.740693.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 47

  1. 10.1016/0028-3908(95)00138-7 · DOI · Paper page
  2. 10.1016/S0165-6147(00)88991-9 · DOI · Paper page
  3. 10.1016/0014-2999(91)90658-D · DOI · Paper page
  4. Benloucif S., 1993, Serotonin‐facilitated dopamine release in vivo: pharmacological characterization., J. Pharmacol. Exp. Ther., 265, 373
  5. Boess F.G., 1998, The 5‐hydroxytryptamine6 receptor‐selective radioligand [3H]Ro 63‐0563 labels 5‐hydroxytryptamine receptor binding sites in rat and porcine striatum., Mol. Pharmacol., 54, 373, 10.1124/mol.54.3.577 · DOI
  6. 10.1016/0028-3908(94)00145-I · DOI
  7. 10.1046/j.1471-4159.1996.66010210.x · DOI
  8. 10.1046/j.1471-4159.1997.68010195.x · DOI
  9. 10.1016/0920-9964(91)90030-U · DOI · Paper page
  10. 10.1016/S0306-4522(98)00655-1 · DOI · Paper page
  11. Dray A., 1981, Serotonin in the basal ganglia: functions and interactions with other neuronal pathways., J. Physiol. (Paris), 77, 393
  12. 10.1016/0006-8993(76)90005-6 · DOI · Paper page
  13. 10.1016/S0306-4522(96)00480-0 · DOI · Paper page
  14. 10.1016/0014-2999(94)90669-6 · DOI
  15. Hoyer D., 1994, International Union of Pharmacology classification of receptors for 5‐hydroxytryptamine (serotonin)., Pharmacol. Rev., 46, 157
  16. 10.1016/0014-2999(93)90859-G · DOI
  17. 10.1111/j.1471-4159.1992.tb10975.x · DOI
  18. 10.1016/0006-8993(95)00865-N · DOI
  19. 10.1111/j.2042-7158.1980.tb12889.x · doi:10.1111/j.2042-7158.1980.tb12889.x
  20. 10.1176/ajp.153.4.466 · DOI · Paper page
  21. 10.1111/j.1476-5381.1996.tb15208.x · DOI · Paper page
  22. 10.1159/000138761 · doi:10.1159/000138761
  23. Lejeune F., 1997, Serotonin (5‐HT)2C receptors inhibit the activity of mesocortical and mesolimbic dopaminergic pathways: a combined dialysis and electrophysiological analysis., Soc. Neurosci. Abstr., 23, 975
  24. Leysen J.E., 1985, Receptor‐binding properties in vitro and in vivo of ritanserin, a very potent and long acting serotonin S2 antagonist., Mol. Pharmacol., 27, 600
  25. Lucas G., 1997, 8‐OH‐DPAT, a 5‐HT1A agonist and ritanserin, a 5‐HT2A/C antagonist, reverse haloperidol‐induced catalepsy in rats independently of striatal dopamine release., Psychopharmacology (Berl.), 131, 57, 10.1007/s002130050265 · DOI
  26. Martin‐Ruíz R., 1997, Activation of dopamine D2 receptors in the dorsal raphe nucleus increases firing rate and 5‐HT release in the rat brain., Soc. Neurosci. Abstr., 23, 2328
  27. Meltzer H.Y., 1991, Effects of antipsychotic drugs on serotonin receptors., Pharmacol. Rev., 43, 587
  28. 10.1016/S0014-2999(98)00321-5 · DOI
  29. 10.1016/0306-4522(90)90330-7 · DOI · Paper page
  30. 10.1016/S0028-3908(98)00078-1 · DOI · Paper page
  31. Monsma F.J., 1993, Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs., Mol. Pharmacol., 43, 320
  32. PaxinosG.&WatsonC.(1986)The Rat Brain in Stereotaxic Coordinates 2nd edit. Academic Press Orlando.
  33. 10.1016/0006-8993(85)90857-1 · DOI · Paper page
  34. 10.1016/0169-328X(94)90223-2 · DOI · Paper page
  35. Rinaldi‐Carmona M., 1992, Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5‐hydroxytryptamine2 receptor antagonist., J. Pharmacol. Exp. Ther., 262, 759
  36. 10.1016/0014-2999(92)90819-P · DOI · Paper page
  37. 10.1046/j.1471-4159.1994.62041382.x · DOI
  38. 10.1016/0006-8993(93)91535-Z · DOI · Paper page
  39. 10.1016/0306-4522(84)90082-4 · DOI
  40. Spampinato U., 1998, Opposite role of central 5‐HT2A and 5‐HT2C receptor subtypes in the control of haloperidol‐induced release of dopamine in the rat striatum., Soc. Neurosci. Abstr., 24, 108
  41. 10.1037/0033-2909.112.2.330 · doi:10.1037/0033-2909.112.2.330 · Paper page
  42. Westphal R.S., 1995, Increased basal phosphorylation of the constitutively active serotonin2C receptor accompanies agonist‐mediated desensitization., Mol. Pharmacol., 48, 200
  43. 10.1002/cne.903510304 · DOI · Paper page
  44. Wurtman R.J., 1998, DOI, a 5‐HT2 receptor agonist, increases both DA and 5‐HT release in rat striatum., Soc. Neurosci. Abstr., 24, 1370
  45. Yamamoto B.K., 1995, Modulation of methylenedioxymethamphetamine‐induced striatal dopamine release by the interaction between serotonin and γ‐aminobutyric acid in the substantia nigra., J. Pharmacol. Exp. Ther., 273, 1063
  46. 10.1016/0014-2999(86)90002-6 · DOI
  47. 10.1016/0014-2999(88)90110-0 · DOI · Paper page

Cited by

See all 170

Metadata

Authors
Lucas, G., & Spampinato, U.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2000-02
Volume
74
Issue
2
Pages
693-701
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2165194242
Cited by
170
References
1
FWCI
5.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of Striatal Serotonin2A and Serotonin2C Receptor Subtypes in the Control of In Vivo Dopamine Outflow in the Rat Striatum. https://app.cochat.ai/papers/10.1046/j.1471-4159.2000.740693.x
The paper
Lucas, G., & Spampinato, U. (2000). Role of Striatal Serotonin2A and Serotonin2C Receptor Subtypes in the Control of In Vivo Dopamine Outflow in the Rat Striatum. Journal of Neurochemistry. https://doi.org/10.1046/j.1471-4159.2000.740693.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.